Anika Therapeutics Inc (ANIK)

R&D to Revenue

22.51%

Quarterly · Period ending:

ANIK logo

ANIK R&D to Revenue

Latest reported22.51%
ANIK Quarterly R&D/Revenue (0.00% → 22.51%)
High-resolution chart · PNG

ANIK r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
22.5115%
22.6699%
21.0746%
24.9703%
22.3715%
23.1542%
-212.2481%
18.6927%
21.7485%
20.1466%
17.6514%
18.7893%
20.121%
22.1496%
19.5573%
18.1328%
17.5883%
16.7798%
16.75%
19.4076%
19.1192%
18.5495%
23.348%
16.4605%
14.7728%
17.0918%
13.7176%
14.0014%
13.6926%
17.2228%
15.0764%
15.7987%
15.4936%
24.2711%
14.5161%
21.4906%
13.2957%
18.0877%
10.3008%
10.9426%
10.5037%
9.689%
9.7624%
8.706%
7.9128%
13.5162%
8.5292%
9.0675%
7.1291%
6.7265%
9.5519%
9.1133%
8.7815%
10.3818%
5.9261%
8.2421%
6.615%
10.6757%
8.2994%
8.2974%
9.7526%
13.0576%
9.4264%
12.7954%
12.6667%
15.046%
12.4198%
22.0717%
24.0057%
23.8503%
27.265%
19.5715%
18.1521%
17.6439%
14.4949%
14.134%
14.0298%
13.8047%
8.5665%
14.5999%
14.4892%
15.4868%
19.9963%
9.7335%
20.812%
16.4449%
13.9368%
15.4206%
17.9655%
14.7696%
13.0834%
13.0694%
19.5298%
23.9066%
19.0216%
30.9129%
30.7063%
45.6068%
37.4921%
27.0608%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.